# RT for Adenocarcinoma/Adenosquamous Carcinoma

> **NCT07153952** · PHASE1,PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Peking Union Medical College Hospital** · enrollment: 60 (estimated)

## Conditions studied

- Cervical Adenocarcinoma
- Cervical Adenosquamous Carcinoma
- Radiotherapy

## Interventions

- **RADIATION:** radiotherapy
- **DRUG:** Systemic treatment

## Key facts

- **NCT ID:** NCT07153952
- **Lead sponsor:** Peking Union Medical College Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-01-01
- **Primary completion:** 2027-01-01
- **Final completion:** 2028-01-01
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2025-09-04

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07153952

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07153952, "RT for Adenocarcinoma/Adenosquamous Carcinoma". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07153952. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*